Saudi hotel industry growth in spotlight at show

The Inter-Hotel Culinary Competition will return for a third time, with more hotels battling against each other by putting forward their top chefs.
Updated 03 April 2019

Saudi hotel industry growth in spotlight at show

The seventh version of the Kingdom’s premier food and hospitality trade event is returning to Jeddah from April 21 to 23, with a range of features, CPD seminars as networking opportunities with industry peers.

The Hotel Show Saudi Arabia 2019 at the Jeddah Center for Forums and Events will serve as a platform to highlight the latest innovations in the food industry and share local and international trends and insights.

Gary Williams, the show’s event director, said: “With tourists’ arrivals in the Kingdom growing year-on-year, hoteliers and restaurateurs understand the need to keep investing and researching to keep up with the increased levels of competition and to better serve their clients.”

Travel bookings in the Kingdom are considered the largest in the Middle East and North Africa (MENA) — worth more than $25 billion each year. The hospitality industry’s growth shows no sign of slowing, with 64,000 hotel rooms and 187 hotel projects forecast to be added to current supply. 

Organizers of the show claim the event provides a 360-degree view of the hospitality industry, with hundreds of global brands from around the world showcasing products across interiors, lighting and design, fitness, technology and security, hygiene, kitchen and laundry equipment, HORECA (hotels, restaurants and catering), F&B (food and beverages) and more. 

Exhibitors from China, Egypt, Oman, Pakistan, Turkey, Portugal, India, France, the UAE, the US, Slovenia and more will be participating in this year’s show. 

The event is visited by more than 6,500 sector professionals — from GMs, owners and operators, through to procurement managers, designers and architects, housekeepers, executive chefs, revenue managers and engineers working in the hospitality industry.  

Following new legislation and government reforms that have made the Kingdom more accessible than ever, Saudi Arabia represents the largest development opportunities in the hospitality industry in the Middle East.

The tourism sector has been earmarked by the government as a key driver for growth in the Kingdom’s Vision 2030 economic diversification strategy, with major initiatives to stimulate the travel and tourism industry.

The event will also include various live kitchens being set up across the show floor with a competitive spirit between rival hotel teams. The Inter-Hotel Culinary Competition will return for a third edition, with more hotels battling against each other by putting forward their top chefs to showcase creative cooking styles and share culinary expertise in a live kitchen environment.

Chefs from Radisson Blu, Somewhere Hotel, Movenpick, Oberoi, Assila, Makarem Ajyad, Intercontinental, Four Seasons, Hyatt, Le Meridien Towers Makkah and more will be competing against each other. Judges include Chef Thomas Gugler, Chef Yasser Jad and more.


Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

Updated 27 May 2020

Clinical trials to accelerate adoption of new drug treatments in Saudi Arabia

  • Trials are being led locally as an essential means to verify the safety and effectiveness of a new drug
  • Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic

RIYADH: Clinical trials in Saudi Arabia could speed up the adoption of new drugs locally, a pharmaceutical executive has told Arab News.

“Clinical trials have two very big benefits for the Kingdom. Firstly, they provide data in the long run with respect to safety and efficacy, catered specifically to the Saudi population. Secondly, they impact local investment and build healthcare capabilities,” Managing Director of Eli Lilly Dimitri Livadas said..

Lividas further explained that the clinical trial phase of any new treatment is crucial as it represents the stage between the adoption or rejection of a drug. Working with the Ministry of Health and with a presence in the Kingdom for 42 years, the pharmaceutical company began research trials in the country in 2016, consisting of five pre-marketing activities and three monitoring studies for post-marketing.

Lividas added that the trials are being led locally as an essential means to verify the safety and effectiveness of a new drug before it is put to the market and introduced to patients. The majority of these are focused on diabetes, oncology, immunology, and osteoporosis.

“We genuinely believe that our future is here in Saudi Arabia. We continue to make great progress in having a commercial organization in the Kingdom that is fully staffed by Saudi nationals,” said Lividas.

As a biopharmaceutical company, Eli Lilly has a major role to play during the coronavirus disease (COVID-19) pandemic. It recently announced partnership with AbCellera to develop a treatment for the virus and aims to enter into clinical trials this year.

“I salute the Saudi authorities for their strong measures to contain the spread of COVID-19. I think it is an example to the world on how to do this. I would like to also express my gratitude toward all healthcare professionals who are currently on the frontlines, risking their own health to help others," Lividas said.